United States · Federal contract register · Supplier record

REDHILL BIOPHARMA LTD

Line: Health r&d services; health care services; experimental development (AN13)Register loaded to September 2026Compiled 17 October 2026

REDHILL BIOPHARMA LTD — United States · Federal contract register · Supplier record: 1 contracts, all years ($733,382 · Sep 2024 – Sep 2024); $733K since January 2024 (1 contract · 1 agency); 55th rank in the line (of 102 suppliers · 0.13%); 3 agencies never served ($80.8M on the line without REDHILL BIOPHARMA LTD).

Assay record ASY-US-1FYSMXH0GW · Cite as: Assay Systems, “REDHILL BIOPHARMA LTD: 1 government contract in the United States since 2024”, https://assay-systems.com/register/us/redhill-biopharma-ltd/

1
contracts, all years
$733,382 · Sep 2024 – Sep 2024
$733K
since January 2024
1 contract · 1 agency
55th
rank in the line
of 102 suppliers · 0.13%
3
agencies never served
$80.8M on the line without REDHILL BIOPHARMA LTD

Own record by year

2024 onward
$733K
202420252026

Who buys from REDHILL BIOPHARMA LTD

since January 2024
1agencies
$733Kpaid
100.0%top buyer
Department of Health and Human Services100.0%
$733,382

Won without a rival

2024-09-27 – 2024-09-27
1uncontested awards
100%of its awards
0without a competition
1single bid

REDHILL BIOPHARMA LTD won 1 of its 1 public contract awards in United States without a rival from 2024-09-27 to 2024-09-27, worth $733K: 0 without a competition and 1 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Office of Assistant Secretary for Preparedness and Response with 1.

Buyers: Office of Assistant Secretary for Preparedness and Response (1)

Every uncontested award of REDHILL BIOPHARMA LTD · United States: all uncontested awards

The line

since January 2024
$566Mline value
124contracts
4agencies
102suppliers
70.3%held by top ten

Health r&d services; health care services; experimental development (AN13)

$239M
$109M
$218M
202420252026Jan–Sep
55thof 102 suppliers
$733,382REDHILL BIOPHARMA LTD in the line
0.13%share of the line
0.2%of $485,502,671 spent by Department of Health and Human Services

Agencies that buy the line and never bought from REDHILL BIOPHARMA LTD

3agencies
61contracts
$80,752,756since January 2024
Department of Defense18 contracts
$50,693,667
Department of the Interior17 contracts
$26,151,140
Department of Veterans Affairs26 contracts
$3,907,948

How the line is bought

by value, since 2024
3%no competition
69%one applicant
0of these to REDHILL BIOPHARMA LTD
Competed, one supplier applied40 contracts
$392,822,700 · 69.4%
Competed, several suppliers applied54 contracts
$155,880,962 · 27.5%
Awarded directly, no competition30 contracts
$17,551,765 · 3.1%

Contracts reaching their end dates

Oct 2026 – October 2027
34contracts
$69,076,959end by October 2027
10end in September 2027 · $35.6M
21in agencies never served · $28.0M
$750K
$1.8M
$69.8K
$1.4M
$1.5M
$13.1M
$186K
$2.0M
$12.6M
$35.6M
Oct 261 contractNov 263 contractsDec 261 contractJan 271 contractFeb 273 contractsMar 2710 contractsMay 271 contractJun 271 contractAug 273 contractsSep 2710 contracts

Suppliers next to it in the line

since January 2024
REDHILL BIOPHARMA LTD
$733,382
AMPLITUDE THERAPEUTICS, INC.1 contract · 1 agency
$732,813
MRIGLOBAL1 contract · 1 agency
$729,864
TIBA BIOTECH LLC1 contract · 1 agency
$726,389

All 102 suppliers in the line

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.